Somna Therapeutics announced that the Food and Drug Administration (FDA) has granted clearance for the Reza Band UES Assist Device to reduce symptoms of laryngopharyngeal reflux (LPR) by stopping regurgitation of stomach contents through the upper esophageal sphincter (UES).
The Reza Band is an externally-worn, non-medication, non-surgical device that works by exerting slight pressure to the cricoid cartilage area, which increases the internal pressure of the UES. This reduces symptoms such as chronic throat irritation, cough, hoarse voice, difficulty swallowing, and postnasal drip.
RELATED: Evaluating Antidepressant Tx in Patients with Functional Esophageal Disorders, GERD
The Reza Band clearance is supported by data from a multi-center clinical study designed to assess safety and effectiveness when worn by patients with LPR. In the study, 86% of patients using the Reza Band experienced a significant reduction in symptoms after 2 weeks. Physician satisfaction with the device was reported 92% of the time, and 75% of patients reported being “satisfied” or “very satisfied.”
The Reza Band is currently available for purchase online only in the United States.
For more information call (262) 345-5553 or visit RezaBand.com.